These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 9398199)
1. Decreased Stability of Transforming Growth Factor beta Type II Receptor mRNA in RER+ Human Colon Carcinoma Cells. Jiang W; Tillekeratne MPM; Brattain MG; Banerji SS Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9398199 [TBL] [Abstract][Full Text] [Related]
2. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells. Jiang W; Tillekeratne MP; Brattain MG; Banerji SS Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753 [TBL] [Abstract][Full Text] [Related]
3. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells. Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759 [TBL] [Abstract][Full Text] [Related]
4. Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells. Chang J; Park K; Bang YJ; Kim WS; Kim D; Kim SJ Cancer Res; 1997 Jul; 57(14):2856-9. PubMed ID: 9230189 [TBL] [Abstract][Full Text] [Related]
5. Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines. Lee HJ; Chang JH; Kim YS; Kim SJ; Yang HK J Exp Clin Cancer Res; 2003 Sep; 22(3):477-80. PubMed ID: 14582709 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines. Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728 [TBL] [Abstract][Full Text] [Related]
7. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532 [TBL] [Abstract][Full Text] [Related]
8. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression. Park SH; Kim YS; Park BK; Hougaard S; Kim SJ Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868 [TBL] [Abstract][Full Text] [Related]
9. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1. Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993 [TBL] [Abstract][Full Text] [Related]
10. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma. Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724 [TBL] [Abstract][Full Text] [Related]
11. Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells. Chang J; Lee C; Hahm KB; Yi Y; Choi SG; Kim SJ Oncogene; 2000 Jan; 19(1):151-4. PubMed ID: 10644990 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154 [TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. Shin KH; Park YJ; Park JG Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536 [TBL] [Abstract][Full Text] [Related]
14. Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells. Yang H; Kyo S; Takatura M; Sun L Cell Growth Differ; 2001 Feb; 12(2):119-27. PubMed ID: 11243466 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells. Park SH; Birchenall-Roberts MC; Yi Y; Lee BI; Lee DK; Bertolette DC; Fu T; Ruscetti F; Kim SJ Cell Growth Differ; 2001 Jan; 12(1):9-18. PubMed ID: 11205746 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation. Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062 [TBL] [Abstract][Full Text] [Related]
17. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression. Mi Y; Borger DR; Fernandes PR; Pirisi L; Creek KE Virology; 2000 May; 270(2):408-16. PubMed ID: 10793000 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Guo Y; Kyprianou N Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855 [TBL] [Abstract][Full Text] [Related]
19. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells. Yang HK; Kang SH; Kim YS; Won K; Bang YJ; Kim SJ Oncogene; 1999 Apr; 18(13):2213-9. PubMed ID: 10327067 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma. Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]